Liposome composition for conveying eye treatment medicament

Liposome composition for conveying eye treatment medicament

The invention discloses a liposome composition for conveying a treatment medicament with a large effective loading amount to an angiogenesis position of a sick eye needing the treatment medicament. The liposome composition in which the treatment medicament is encapsulated comprises a particle formin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIU JUNREN, ZENG YUNLONG, GUO SONGSHENG, HONG JILONG, LAI QIJUN
Format: Patent
Sprache:chi ; eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIU JUNREN
ZENG YUNLONG
GUO SONGSHENG
HONG JILONG
LAI QIJUN
description The invention discloses a liposome composition for conveying a treatment medicament with a large effective loading amount to an angiogenesis position of a sick eye needing the treatment medicament. The liposome composition in which the treatment medicament is encapsulated comprises a particle forming component consisting of a plurality of vesiculation forming liposomes and a medicament carrier component capable of forming a complex together with the treatment medicament under the interaction of static electricity and static electricity or the interaction of a hydrophobic group and a hydrophobic group. The average particle size of the liposome composition comprising the treatment medicament is about 30 to 200 nanometers. The liposomes accumulated at the angiogenesis position of the eye can be detected 24 hours after the liposome composition comprising the treatment medicament is given to a patient through intravenous injection. The invention also discloses a method for conveying the treatment medicament to the
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN101933905A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN101933905A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN101933905A3</originalsourceid><addsrcrecordid>eNrjZLD2ySzIL87PTVVIzs8FsjJLMvPzFNLyi4D8vLLUysy8dIXUylSFkqLUxJLc1LwShdzUlMzkRBCTh4E1LTGnOJUXSnMzKLq5hjh76KYW5MenFhckJqfmpZbEO_sZGhhaGhtbGpg6GhOjBgAGrDAj</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Liposome composition for conveying eye treatment medicament</title><source>esp@cenet</source><creator>LIU JUNREN ; ZENG YUNLONG ; GUO SONGSHENG ; HONG JILONG ; LAI QIJUN</creator><creatorcontrib>LIU JUNREN ; ZENG YUNLONG ; GUO SONGSHENG ; HONG JILONG ; LAI QIJUN</creatorcontrib><description>The invention discloses a liposome composition for conveying a treatment medicament with a large effective loading amount to an angiogenesis position of a sick eye needing the treatment medicament. The liposome composition in which the treatment medicament is encapsulated comprises a particle forming component consisting of a plurality of vesiculation forming liposomes and a medicament carrier component capable of forming a complex together with the treatment medicament under the interaction of static electricity and static electricity or the interaction of a hydrophobic group and a hydrophobic group. The average particle size of the liposome composition comprising the treatment medicament is about 30 to 200 nanometers. The liposomes accumulated at the angiogenesis position of the eye can be detected 24 hours after the liposome composition comprising the treatment medicament is given to a patient through intravenous injection. The invention also discloses a method for conveying the treatment medicament to the</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110105&amp;DB=EPODOC&amp;CC=CN&amp;NR=101933905A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110105&amp;DB=EPODOC&amp;CC=CN&amp;NR=101933905A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIU JUNREN</creatorcontrib><creatorcontrib>ZENG YUNLONG</creatorcontrib><creatorcontrib>GUO SONGSHENG</creatorcontrib><creatorcontrib>HONG JILONG</creatorcontrib><creatorcontrib>LAI QIJUN</creatorcontrib><title>Liposome composition for conveying eye treatment medicament</title><description>The invention discloses a liposome composition for conveying a treatment medicament with a large effective loading amount to an angiogenesis position of a sick eye needing the treatment medicament. The liposome composition in which the treatment medicament is encapsulated comprises a particle forming component consisting of a plurality of vesiculation forming liposomes and a medicament carrier component capable of forming a complex together with the treatment medicament under the interaction of static electricity and static electricity or the interaction of a hydrophobic group and a hydrophobic group. The average particle size of the liposome composition comprising the treatment medicament is about 30 to 200 nanometers. The liposomes accumulated at the angiogenesis position of the eye can be detected 24 hours after the liposome composition comprising the treatment medicament is given to a patient through intravenous injection. The invention also discloses a method for conveying the treatment medicament to the</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD2ySzIL87PTVVIzs8FsjJLMvPzFNLyi4D8vLLUysy8dIXUylSFkqLUxJLc1LwShdzUlMzkRBCTh4E1LTGnOJUXSnMzKLq5hjh76KYW5MenFhckJqfmpZbEO_sZGhhaGhtbGpg6GhOjBgAGrDAj</recordid><startdate>20110105</startdate><enddate>20110105</enddate><creator>LIU JUNREN</creator><creator>ZENG YUNLONG</creator><creator>GUO SONGSHENG</creator><creator>HONG JILONG</creator><creator>LAI QIJUN</creator><scope>EVB</scope></search><sort><creationdate>20110105</creationdate><title>Liposome composition for conveying eye treatment medicament</title><author>LIU JUNREN ; ZENG YUNLONG ; GUO SONGSHENG ; HONG JILONG ; LAI QIJUN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN101933905A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2011</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LIU JUNREN</creatorcontrib><creatorcontrib>ZENG YUNLONG</creatorcontrib><creatorcontrib>GUO SONGSHENG</creatorcontrib><creatorcontrib>HONG JILONG</creatorcontrib><creatorcontrib>LAI QIJUN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIU JUNREN</au><au>ZENG YUNLONG</au><au>GUO SONGSHENG</au><au>HONG JILONG</au><au>LAI QIJUN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Liposome composition for conveying eye treatment medicament</title><date>2011-01-05</date><risdate>2011</risdate><abstract>The invention discloses a liposome composition for conveying a treatment medicament with a large effective loading amount to an angiogenesis position of a sick eye needing the treatment medicament. The liposome composition in which the treatment medicament is encapsulated comprises a particle forming component consisting of a plurality of vesiculation forming liposomes and a medicament carrier component capable of forming a complex together with the treatment medicament under the interaction of static electricity and static electricity or the interaction of a hydrophobic group and a hydrophobic group. The average particle size of the liposome composition comprising the treatment medicament is about 30 to 200 nanometers. The liposomes accumulated at the angiogenesis position of the eye can be detected 24 hours after the liposome composition comprising the treatment medicament is given to a patient through intravenous injection. The invention also discloses a method for conveying the treatment medicament to the</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN101933905A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Liposome composition for conveying eye treatment medicament
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T18%3A07%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIU%20JUNREN&rft.date=2011-01-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN101933905A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true